Stock Scorecard
Stock Summary for Prenetics Global Ltd - Class A (PRE) - $15.90 as of 5/7/2026 11:55:45 AM EST
Total Score
10 out of 30
Safety Score
30 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for PRE
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for PRE
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for PRE
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for PRE
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for PRE (30 out of 100)
| Stock Price Rating (Max of 10) | 6 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 5 |
| Book Value to Price (Max of 10) | 1 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for PRE
Financial Details for PRE
Company Overview |
|
|---|---|
| Ticker | PRE |
| Company Name | Prenetics Global Ltd - Class A |
| Country | USA |
| Description | Prenetics Global Ltd (PRE) is a premier health technology innovator focused on delivering advanced genetic and diagnostic testing solutions that empower consumers and healthcare professionals with critical health insights. With a diverse portfolio of state-of-the-art testing services and integrated digital health offerings, the company has seen significant international growth, fueled by strategic partnerships and a strong commitment to ongoing research and development. As a frontrunner in the personalized medicine space, Prenetics is ideally positioned to capitalize on the increasing demand for accessible and actionable health information, representing a compelling investment opportunity in the dynamic healthcare landscape. |
| Sector Name | HEALTHCARE |
| Industry Name | DIAGNOSTICS & RESEARCH |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | 6/11/2026 |
Stock Price History |
|
| Last Day Price | 15.90 |
| Price 4 Years Ago | 30.00 |
| Last Day Price Updated | 5/7/2026 11:55:45 AM EST |
| Last Day Volume | 261,512 |
| Average Daily Volume | 157,514 |
| 52-Week High | 23.63 |
| 52-Week Low | 5.08 |
| Last Price to 52 Week Low | 212.99% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 29.85 |
| Sector PE | 78.09 |
| 5-Year Average PE | 34.98 |
| Free Cash Flow Ratio | 7.57 |
| Industry Free Cash Flow Ratio | 52.67 |
| Sector Free Cash Flow Ratio | 24.49 |
| Current Ratio Most Recent Quarter | 3.01 |
| Total Cash Per Share | 2.10 |
| Book Value Per Share Most Recent Quarter | 10.89 |
| Price to Book Ratio | 1.77 |
| Industry Price to Book Ratio | 7.37 |
| Sector Price to Book Ratio | 9.85 |
| Price to Sales Ratio Twelve Trailing Months | 3.08 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.92 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.08 |
| Analyst Buy Ratings | 2 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 15,419,400 |
| Market Capitalization | 245,168,460 |
| Institutional Ownership | 11.41% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -25.96% |
| Reported EPS 12 Trailing Months | -2.46 |
| Reported EPS Past Year | -2.82 |
| Reported EPS Prior Year | -4.58 |
| Net Income Twelve Trailing Months | -76,048,000 |
| Net Income Past Year | -58,323,999 |
| Net Income Prior Year | -46,304,000 |
| Quarterly Revenue Growth YOY | 248.60% |
| 5-Year Revenue Growth | 7.23% |
| Operating Margin Twelve Trailing Months | -33.30% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 32,131,000 |
| Total Cash Past Year | 32,131,000 |
| Total Cash Prior Year | 52,251,000 |
| Net Cash Position Most Recent Quarter | 32,131,000 |
| Net Cash Position Past Year | 32,131,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 174,602,000 |
| Total Stockholder Equity Prior Year | 170,389,000 |
| Total Stockholder Equity Most Recent Quarter | 174,602,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -44,038,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -2.86 |
| Free Cash Flow Past Year | -22,019,000 |
| Free Cash Flow Prior Year | -29,939,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.42 |
| MACD Signal | -0.35 |
| 20-Day Bollinger Lower Band | 14.87 |
| 20-Day Bollinger Middle Band | 18.30 |
| 20-Day Bollinger Upper Band | 21.72 |
| Beta | 0.15 |
| RSI | 48.60 |
| 50-Day SMA | 13.47 |
| 150-Day SMA | 8.41 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 5/7/2026 6:21:57 AM EST |